BMED vs TRUF

BMEDBiShares Health Innovation Active ETF

TRUFCVanEck Financials TruSector ETF

In short

BMED Most health ETFs are a shelf of mega-cap pharma. BMED's stock pickers hunt the other end: roughly 60 innovative and emerging health names tilted to mid and small caps worldwide, 0.55% net of a waiver through June 30, 2027.

TRUF Most active funds exist to beat a benchmark. TRUF is active so it can hug one: it holds US financials at true market weight, sidestepping the diversification caps that force many sector funds to shrink their largest names.

Stated mandate

BMED The Fund seeks to maximize total return through active investment in innovative and emerging healthcare companies.

TRUF The Fund is an actively managed ETF seeking long-term capital appreciation through securities of financials-related companies or instruments providing exposure to such companies.

Why people hold it

• BMED Mandate is specific: at least 80% of net assets in health sciences stocks, with the focus on mid- and small-cap innovators anywhere in the world, emerging markets included.sec.gov
• 0.55% net of a waiver through June 30, 2027 (0.77% gross), below the median fee among the 35 active sector funds in its group.
• Reach goes past drugmakers: devices, diagnostics, REITs that own hospitals, even animal and plant health sit inside the prospectus definition.sec.gov
• About 60 names means each pick carries weight, and the portfolio matches the innovation mandate it advertises, one of the stronger builds in its active sector peer group.

• TRUF A 0.10% expense ratio, against a 0.65% median for actively managed US equity funds in its peer group.
• The hybrid build (individual stocks plus targeted ETFs) keeps a sector's biggest contributors at uncapped weight while staying inside fund diversification rules.businesswire.comvaneck.com
• Roughly 80 names, measured against the MarketVector Top US Financials Companies Index. The mandate is the sector itself, not a stock picker's shortlist.

Worth knowing

• BMED Small fund, light trading. Spreads can widen and the market price can drift from net asset value, which bites hardest on bigger orders.sec.gov
• Mid caps, small caps and emerging-market names in a book of about 60 stocks move harder in both directions than mega-cap pharma.sec.gov
• That 0.55% leans on a waiver running to June 30, 2027; gross is 0.77%. Active healthcare peer TMED charges 0.44% with no waiver attached.

• TRUF VanEck says financials has not suffered the weighting distortions that hit tech and consumer discretionary, so the problem this structure solves is smaller here.vaneck.com
• Launched in 2026 and still a small fund, so spreads can run wider than in the sector's household-name ETFs. Limit orders are the usual tool for that.
• Owning other ETFs brings acquired fund fees, one of the items VanEck's expense arrangement does not cover, so total cost sits above the headline fee.vaneck.com

Full BMED profile⁠

Full TRUF profile⁠